SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-23-061936
Filing Date
2023-05-17
Accepted
2023-05-17 17:04:21
Documents
6
Period of Report
2023-06-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm231896-2_def14a.htm DEF 14A 704819
2 GRAPHIC lg_bioxcelthera-4c.jpg GRAPHIC 84745
3 GRAPHIC px_bioxcelannualmeet01-bw.jpg GRAPHIC 633551
4 GRAPHIC px_bioxcelannualmeet02-bw.jpg GRAPHIC 579720
5 GRAPHIC sg_javierrodriguez-bw.jpg GRAPHIC 39302
6 GRAPHIC sg_petermueller-bw.jpg GRAPHIC 13058
  Complete submission text file 0001104659-23-061936.txt   2325103
Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Filer) CIK: 0001720893 (see all company filings)

IRS No.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38410 | Film No.: 23932679
SIC: 2834 Pharmaceutical Preparations